National and Kapodistrian University of Athens
Προσδιορισμός των μεταλλάξεων του BRAF γονιδίου στον καρκίνο του παχέος εντέρου
Abstract
dc:descriptionOur aim was to evaluate the predictive and prognosticinfluence of BRAF mutation and other molecular, clinicaland laboratory parameters in stage IV colorectal cancer(CRC). 60 patients were included in this retrospective analysis,and 17 variables were examined for their relation withtreatment response and survival. KRAS mutation was identifiedin 40.3 % of cases, BRAF and PIK3CA in 8.8 % and10.5 % respectively. 29.8 % of patients responded to treatment.Median survival time was 14.3 months. Weight loss,fever, abdominal metastases, blood transfusion,hypoalbuminaimia, BRAF and PIK3CA mutations, CRP andDNA Index were associated with survival. In multivariateanalysis, male patients had 3.8 times higher probability ofresponse, increased DNA Index was inversely correlated withresponse and one unit raise of DNA Index augmented 6 timesthe probability of death. Our findings potentiate the prognosticrole of BRAF, PIK3CA mutations and ploidy in advancedCRC.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2016
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Karadima, Maria
- Καραδήμα, Μαρία
Subjects
dc:subject × 13Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/37953